| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |